Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Proszek, PZ"'
Autor:
Shah, V, Sherborne, AL, Walker, BA, Johnson, DC, Boyle, EM, Ellis, S, Begum, DB, Proszek, PZ, Jones, JR, Pawlyn, C, Savola, S, Jenner, MW, Drayson, MT, Owen, RG, Houlston, RS, Cairns, DA, Gregory, WM, Cook, G, Davies, F, Jackson, GH, Morgan, GJ, Kaiser, MF
Robust establishment of survival in multiple myeloma (MM) and its relationship to recurrent genetic aberrations is required as outcomes are variable despite apparent similar staging. We assayed copy number alterations (CNA) and translocations in 1036
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=core_ac_uk__::85ee3ae844525eae55a5c49d73e065df
https://eprints.whiterose.ac.uk/117302/16/leu2017179a.pdf
https://eprints.whiterose.ac.uk/117302/16/leu2017179a.pdf
Autor:
Cortes-Ciriano I; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, United Kingdom., Steele CD; Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, United Kingdom., Piculell K; Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts., Al-Ibraheemi A; Department of Pathology, Boston Children's Hospital, Boston, Massachusetts., Eulo V; Division of Oncology, Department of Internal Medicine, University of Alabama at Birmingham, Birmingham, Alabama., Bui MM; Department of Pathology, Moffitt Cancer Center & Research Institute, Tampa, Florida., Chatzipli A; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Dickson BC; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.; Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada., Borcherding DC; Division of Oncology, Departments of Internal Medicine and Pediatrics, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri., Feber A; Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom., Galor A; Wellcome Centre for Human Genetics, University of Oxford, Oxford, United Kingdom., Hart J; Department of Pathology, Lifespan Laboratories, Rhode Island Hospital, Providence, Rhode Island., Jones KB; Departments of Orthopaedics and Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Jordan JT; Pappas Center for Neuro-oncology, Massachusetts General Hospital, Boston, Massachusetts., Kim RH; Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Sinai Health System, Toronto, Ontario, Canada.; Hospital for Sick Children, University of Toronto, Ontario Institute for Cancer Research, Toronto, Ontario, Canada., Lindsay D; Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, United Kingdom., Miller C; European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, Cambridge, United Kingdom., Nishida Y; Department of Rehabilitation Medicine, Nagoya University Hospital, Nagoya, Aichi, Japan., Proszek PZ; Clinical Genomics Translational Research, Institute of Cancer Research, Royal Marsden NHS Foundation Trust, London, United Kingdom., Serrano J; Department of Pathology, New York University Langone Health, Perlmutter Cancer Center, New York City, New York., Sundby RT; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland., Szymanski JJ; Division of Cancer Biology, Department of Radiation Oncology, Washington University School of Medicine, St. Louis, Missouri., Ullrich NJ; Department of Neurology, Boston Children's Hospital, Boston, Massachusetts., Viskochil D; Division of Medical Genetics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Wang X; GeneHome, Department of Individualized Cancer Management, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida., Snuderl M; Department of Pathology, New York University Langone Health, Perlmutter Cancer Center, New York City, New York., Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts., Flanagan AM; Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, United Kingdom.; Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, United Kingdom., Hirbe AC; Division of Oncology, Departments of Internal Medicine and Pediatrics, Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri., Pillay N; Research Department of Pathology, University College London Cancer Institute, Bloomsbury, London, United Kingdom.; Department of Histopathology, Royal National Orthopaedic Hospital, NHS Trust, Middlesex, United Kingdom., Miller DT; Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.
Publikováno v:
Cancer discovery [Cancer Discov] 2023 Mar 01; Vol. 13 (3), pp. 654-671.
Autor:
Izquierdo E; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Carvalho DM; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Mackay A; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Temelso S; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Boult JKR; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Pericoli G; Department of Haematology/Oncology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Fernandez E; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Das M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Molinari V; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Grabovska Y; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Rogers RF; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Ajmone-Cat MA; National Centre for Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy., Proszek PZ; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Stubbs M; Division of Cancer Therapeutics, Institute of Cancer Research, London, United Kingdom., Depani S; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., O'Hare P; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Yu L; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Roumelioti G; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Choudhary JS; Division of Cancer Biology, Institute of Cancer Research, London, United Kingdom., Clarke M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Fairchild AR; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Jacques TS; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Grundy RG; Children's Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham, United Kingdom., Howell L; Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom., Picton S; Leeds Children's Hospital, Leeds, United Kingdom., Adamski J; Birmingham Women's and Children's Hospital, Birmingham, United Kingdom., Wilson S; Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom., Gray JC; Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Zebian B; Department of Neurosurgery, Kings College Hospital NHS Trust, London, United Kingdom., Marshall LV; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Carceller F; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Grill J; Department of Pediatric and Adolescent Oncology and INSERM Unit U891, Team 'Genomics and Oncogenesis of Pediatric Brain Tumors,' Gustave Roussy and University Paris-Saclay, Villejuif, France., Vinci M; Department of Haematology/Oncology, Gene and Cell Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Hubank M; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Hargrave D; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom.; UCL Great Ormond Street Institute for Child Health, London, United Kingdom., Jones C; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2022 Mar 01; Vol. 12 (3), pp. 712-729.
Autor:
Stankunaite R; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Electronic address: Reda.stankunaite@icr.ac.uk., George SL; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: sally.george@icr.ac.uk., Gallagher L; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: lewis.gallagher@icr.ac.uk., Jamal S; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: sabri.jamal@icr.ac.uk., Shaikh R; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Ridwan.Shaikh@icr.ac.uk., Yuan L; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Lina.Yuan@icr.ac.uk., Hughes D; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: debbie.hughes@icr.ac.uk., Proszek PZ; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Paula.Proszek@icr.ac.uk., Carter P; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Paul.Carter@icr.ac.uk., Pietka G; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Grzegorz.Pietka@icr.ac.uk., Heide T; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Electronic address: Timon.Heide@icr.ac.uk., James C; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Electronic address: chela.james@icr.ac.uk., Tari H; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK; Glioma Lab, The Institute of Cancer Research, London, UK. Electronic address: Haider.Tari@icr.ac.uk., Lynn C; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Electronic address: Claire.Lynn@icr.ac.uk., Jain N; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Electronic address: Neha.Jain@gosh.nhs.uk., Portela LR; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK. Electronic address: Laura.ReyPortela@gosh.nhs.uk., Rogers T; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK. Electronic address: tony.rogers@icr.ac.uk., Vaidya SJ; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Sucheta.Vaidya@icr.ac.uk., Chisholm JC; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Julia.Chisholm@icr.ac.uk., Carceller F; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Fernando.Carceller@rmh.nhs.uk., Szychot E; Oak Centre for Children and Young People, Royal Marsden NHS Foundation Trust Hospital, Sutton, UK; Department of Paediatrics, Paediatric Oncology and Immunology, Pomeranian Medical University, Szczecin, Poland. Electronic address: e.szychot@nhs.net., Mandeville H; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Henry.Mandeville@rmh.nhs.uk., Angelini P; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: paola.angelini@nhs.net., Jesudason AB; Department of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh, UK., Jackson M; Department of Paediatric Haematology and Oncology, Royal Hospital for Sick Children, Edinburgh, UK., Marshall LV; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: LynleyVanessa.Marshall@icr.ac.uk., Gatz SA; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK; Sarcoma Molecular Pathology Team, Divisions of Molecular Pathology and Cancer Therapeutics, The Institute of Cancer Research, London, UK. Electronic address: S.Gatz@bham.ac.uk., Anderson J; Department of Haematology and Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; Developmental Biology and Cancer Programme, UCL GOS Institute of Child Health, London, UK. Electronic address: j.anderson@ucl.ac.uk., Sottoriva A; Evolutionary Genomics and Modelling Lab, Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. Electronic address: andrea.sottoriva@icr.ac.uk., Chesler L; Paediatric Tumour Biology, Division of Clinical Studies, The Institute of Cancer Research, London, UK; Children and Young People's Unit, Royal Marsden NHS Foundation Trust, London, UK. Electronic address: Louis.Chesler@icr.ac.uk., Hubank M; Molecular Pathology Section, The Institute of Cancer Research, London, UK; Clinical Genomics, The Royal Marsden NHS Foundation, London, UK. Electronic address: Michael.Hubank@icr.ac.uk.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Feb; Vol. 162, pp. 209-220. Date of Electronic Publication: 2021 Dec 18.
Autor:
Deveson IW; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia., Gong B; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Lai K; Bioinformatics, Integrated DNA Technologies, Inc., Coralville, IA, USA., LoCoco JS; Illumina, Inc., San Diego, CA, USA., Richmond TA; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Schageman J; Clinical Sequencing Division, Thermo Fisher Scientific, Austin, TX, USA., Zhang Z; Research and Development, Burning Rock Biotech, Shanghai, China., Novoradovskaya N; Agilent Technologies, La Jolla, CA, USA., Willey JC; Departments of Medicine, Pathology, and Cancer Biology, College of Medicine and Life Sciences, University of Toledo Health Sciences Campus, Toledo, OH, USA., Jones W; Q2 Solutions - EA Genomics, Morrisville, NC, USA., Kusko R; Immuneering Corporation, Cambridge, MA, USA., Chen G; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA., Madala BS; Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia., Blackburn J; Cancer Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia.; St. Vincent's Clinical School, University of New South Wales, Sydney, NSW, Australia., Stevanovski I; Kinghorn Centre for Clinical Genomics, Garvan Institute of Medical Research, Sydney, NSW, Australia., Bhandari A; ResearchDx, Inc., Irvine, CA, USA., Close D; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Conroy J; OmniSeq, Inc., Buffalo, NY, USA., Hubank M; NIHR Biomedical Research Centre, Royal Marsden Hospital, Sutton, Surrey, UK., Marella N; Cancer Genetics, Inc., Rutherford, NJ, USA., Mieczkowski PA; Department of Genetics, University of North Carolina, Chapel Hill, NC, USA., Qiu F; Research and Development, Burning Rock Biotech, Shanghai, China., Sebra R; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Stetson D; Astrazeneca Pharmaceuticals, Waltham, MA, USA., Sun L; Elim Biopharmaceuticals, Inc., Hayward, CA, USA., Szankasi P; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Tan H; Primbio Genes Biotechnology, East Lake High-tech Development Zone, Wuhan, Hubei, China., Tang LY; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Arib H; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Best H; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA.; Departments of Pathology and Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA., Burgher B; OmniSeq, Inc., Buffalo, NY, USA., Bushel PR; National Institute of Environmental Health Sciences, Research Triangle Park, Morrisville, NC, USA., Casey F; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Cawley S; Clinical Sequencing Division, Thermo Fisher Scientific, South San Francisco, CA, USA., Chang CJ; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA., Choi J; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA., Dinis J; Roche Sequencing Solutions, Inc., Pleasanton, CA, USA., Duncan D; Cancer Genetics, Inc., Rutherford, NJ, USA., Eterovic AK; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Feng L; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Ghosal A; ResearchDx, Inc., Irvine, CA, USA., Giorda K; Marketing, Integrated DNA Technologies, Inc., Coralville, IA, USA., Glenn S; OmniSeq, Inc., Buffalo, NY, USA., Happe S; Agilent Technologies, Cedar Creek, TX, USA., Haseley N; Illumina, Inc., San Diego, CA, USA., Horvath K; ResearchDx, Inc., Irvine, CA, USA., Hung LY; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Jarosz M; NGS Products and Services, Integrated DNA Technologies, Inc., Coralville, IA, USA., Kushwaha G; Market & Application Development Bioinformatics, Roche Sequencing Solutions Inc., Pleasanton, CA, USA., Li D; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Li QZ; Department of Immunology, Genomics and Microarray Core Facility, University of Texas Southwestern Medical Center, Dallas, TX, USA., Li Z; Intramural Research Program, Laboratory of Epidemiology and Population Sciences, National Institute on Aging, National Institutes of Health, Baltimore, MD, USA., Liu LC; Clinical Diagnostic Division, Thermo Fisher Scientific, Fremont, CA, USA., Liu Z; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Ma C; Cancer Genetics, Inc., Rutherford, NJ, USA., Mason CE; Department of Physiology and Biophysics, Weill Cornell Medicine, Cornell University, New York, NY, USA., Megherbi DB; CMINDS Research Center, Department of Electrical and Computer Engineering, College of Engineering, University of Massachusetts Lowell, Lowell, MA, USA., Morrison T; Accugenomics, Inc., Wilmington, NC, USA., Pabón-Peña C; Agilent Technologies, Santa Clara, CA, USA., Pirooznia M; Bioinformatics and Computational Biology Laboratory, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA., Proszek PZ; NIHR Biomedical Research Centre, Royal Marsden Hospital, Sutton, Surrey, UK., Raymond A; Astrazeneca Pharmaceuticals, Waltham, MA, USA., Rindler P; R&D Genomics MPS, Institute for Clinical and Experimental Pathology ARUP Laboratories, Salt Lake City, UT, USA., Ringler R; ResearchDx, Inc., Irvine, CA, USA., Scherer A; Institute for Molecular Medicine Finland (FIMM), Nordic EMBL Partnership for Molecular Medicine, HiLIFE Unit, Biomedicum Helsinki 2U (D302b), University of Helsinki, Helsinki, Finland.; EATRIS ERIC- European Infrastructure for Translational Medicine, Amsterdam, The Netherlands., Shaknovich R; Cancer Genetics, Inc., Rutherford, NJ, USA., Shi T; Center for Bioinformatics and Computational Biology and the Institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, China., Smith M; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Song P; Institute for Personalized Cancer Therapy, MD Anderson Cancer Center, Houston, TX, USA., Strahl M; Icahn Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Thodima VJ; Cancer Genetics, Inc., Rutherford, NJ, USA., Tom N; EATRIS ERIC- European Infrastructure for Translational Medicine, Amsterdam, The Netherlands.; Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Verma S; ResearchDx, Inc., Irvine, CA, USA., Wang J; Research and Development, Integrated DNA Technologies, Inc., Coralville, IA, USA., Wu L; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Xiao W; Stanford Genome Technology Center, Stanford University, Palo Alto, CA, USA.; Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA., Xu C; Research and Development, QIAGEN Sciences, Inc., Frederick, MD, USA., Yang M; Department of Information Science, University of Arkansas at Little Rock, Little Rock, AR, USA., Zhang G; Clinical Laboratory, Burning Rock Biotech, Guangzhou, China., Zhang S; Clinical Laboratory, Burning Rock Biotech, Guangzhou, China., Zhang Y; Elim Biopharmaceuticals, Inc., Hayward, CA, USA., Shi L; State Key Laboratory of Genetic Engineering, School of Life Sciences and Shanghai Cancer Hospital/Cancer Institute, Fudan University, Shanghai, China.; Human Phenome Institute, Fudan University, Shanghai, China.; Fudan-Gospel Joint Research Center for Precision Medicine, Fudan University, Shanghai, China., Tong W; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA., Johann DJ Jr; Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. djjohann@uams.edu., Mercer TR; St. Vincent's Clinical School, Faculty of Medicine, University of New South Wales, Sydney, NSW, Australia. t.mercer@garvan.org.au.; Genomics and Epigenetics Theme, Garvan Institute of Medical Research, Sydney, NSW, Australia. t.mercer@garvan.org.au.; Australian Institute of Bioengineering and Nanotechnology, University of Queensland, Queensland, QLD, Australia. t.mercer@garvan.org.au., Xu J; Division of Bioinformatics and Biostatistics, National Center for Toxicological Research, US Food and Drug Administration, Jefferson, AR, USA. joshua.xu@fda.hhs.gov.
Publikováno v:
Nature biotechnology [Nat Biotechnol] 2021 Sep; Vol. 39 (9), pp. 1115-1128. Date of Electronic Publication: 2021 Apr 12.
Autor:
Pascual J; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Lim JSJ; National University Cancer Institute, Singapore (NCIS), National University Hospital, Singapore., Macpherson IR; Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom., Armstrong AC; Department of Medical Oncology, Christie Hospital NHS Foundation Trust and Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom., Ring A; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Okines AFC; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., Cutts RJ; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Herrera-Abreu MT; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Garcia-Murillas I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Pearson A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Hrebien S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Gevensleben H; University Hospital Bonn, Bonn, Germany., Proszek PZ; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Hubank M; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, London, United Kingdom., Hills M; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom., King J; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Parmar M; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Prout T; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Finneran L; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Malia J; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Swales KE; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Ruddle R; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Raynaud FI; Division of Cancer Therapeutics, The Institute of Cancer Research, London, United Kingdom., Turner A; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Hall E; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas., Lopez JS; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom., Turner NC; Breast Unit, The Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom. nick.turner@icr.ac.uk.; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom.; Ralph Lauren Centre for Breast Cancer Research, Royal Marsden Hospital NHS Foundation Trust, London, United Kingdom.
Publikováno v:
Cancer discovery [Cancer Discov] 2021 Jan; Vol. 11 (1), pp. 92-107. Date of Electronic Publication: 2020 Sep 21.
Autor:
Clarke M; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Mackay A; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Ismer B; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Pickles JC; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Tatevossian RG; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Newman S; Department of Computational Biology, St. Jude Children's Research Hospital, Memphis, Tennessee., Bale TA; Department of Neuropathology, Memorial Sloan-Kettering Cancer Center, New York, New York., Stoler I; Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany., Izquierdo E; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Temelso S; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Carvalho DM; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Molinari V; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Burford A; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Howell L; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom., Virasami A; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Fairchild AR; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Avery A; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Chalker J; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Kristiansen M; UCL Great Ormond Street Institute of Child Health, London, United Kingdom., Haupfear K; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Dalton JD; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Orisme W; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Wen J; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee., Hubank M; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Kurian KM; Brain Tumour Research Centre, University of Bristol, Bristol, United Kingdom., Rowe C; Brain Tumour Research Centre, University of Bristol, Bristol, United Kingdom., Maybury M; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Australia.; Oncology Service, Queensland Children's Hospital, Brisbane, Australia.; Child Health Research Centre, The University of Queensland, South Brisbane, Australia., Crosier S; Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Knipstein J; Division of Pediatric Hematology/Oncology/BMT, Medical College of Wisconsin, Milwaukee, Wisconsin., Schüller U; Department of Neuropathology, University Hospital Hamburg-Eppendorf, and Research Institute Children's Cancer Center, Hamburg, Germany.; Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Kordes U; Pediatric Hematology and Oncology, University Hospital Hamburg-Eppendorf, Hamburg, Germany., Kram DE; Section of Pediatric Hematology-Oncology, Wake Forest School of Medicine, Winston-Salem, North Carolina., Snuderl M; Department of Neuropathology, NYU Langone Health, New York, New York., Bridges L; Department of Neuropathology, St George's Hospital NHS Trust, London, United Kingdom., Martin AJ; Department of Neurosurgery, St George's Hospital NHS Trust, London, United Kingdom., Doey LJ; Department of Clinical Neuropathology, Kings College Hospital NHS Trust, London, United Kingdom., Al-Sarraj S; Department of Clinical Neuropathology, Kings College Hospital NHS Trust, London, United Kingdom., Chandler C; Department of Neurosurgery, Kings College Hospital NHS Trust, London, United Kingdom., Zebian B; Department of Neurosurgery, Kings College Hospital NHS Trust, London, United Kingdom., Cairns C; Department of Neurosurgery, Kings College Hospital NHS Trust, London, United Kingdom., Natrajan R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, United Kingdom., Boult JKR; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Robinson SP; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London, United Kingdom., Sill M; German Cancer Research Center (DKFZ), Heidelberg, Germany., Dunkel IJ; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York., Gilheeney SW; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York., Rosenblum MK; Department of Neuropathology, Memorial Sloan-Kettering Cancer Center, New York, New York., Hughes D; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Proszek PZ; Molecular Diagnostics, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Macdonald TJ; Aflac Cancer and Blood Disorders Center, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia., Preusser M; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria., Haberler C; Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.; Institute of Neurology, Medical University of Vienna, Vienna, Austria., Slavc I; Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria., Packer R; Center for Neuroscience and Behavioural Medicine, Children's National Medical Center, Washington, DC., Ng HK; Department of Anatomical and Cellular Pathology, The Chinese University of Hong Kong, China., Caspi S; Cancer Research Center, Sheba Medical Center, Tel Aviv, Israel., Popović M; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Faganel Kotnik B; Department of Hematology and Oncology, University Children's Hospital, Ljubljana, Slovenia., Wood MD; Department of Pathology, Oregon Health & Science University, Portland, Oregon., Baird L; Department of Neurosurgery, Oregon Health & Science University, Portland, Oregon., Davare MA; Department of Pediatrics, Oregon Health & Science University, Portland, Oregon., Solomon DA; Department of Pathology, University of California, San Francisco, California.; Clinical Cancer Genomics Laboratory, University of California, San Francisco, California., Olsen TK; Department of Women's and Children's Health, Karolinska Institute, Stockholm, Sweden., Brandal P; Department of Oncology, Oslo University Hospital, Oslo, Norway., Farrell M; Department of Histopathology, Beaumont Hospital, Dublin, Ireland., Cryan JB; Department of Histopathology, Beaumont Hospital, Dublin, Ireland., Capra M; Paediatric Oncology, Our Lady's Children's Hospital, Dublin, Ireland., Karremann M; Department of Pediatrics, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Schittenhelm J; Institute of Pathology and Neuropathology, University Hospital Tübingen, Germany., Schuhmann MU; Department of Neurosurgery, University Hospital Tübingen, Germany., Ebinger M; Department of Pediatric Hematology and Oncology, University Hospital Tübingen, Germany., Dinjens WNM; Department of Pathology, Erasmus Medical Center, Rotterdam, the Netherlands., Kerl K; Department of Pediatric Hematology and Oncology, University Hospital Muenster, Germany., Hettmer S; Department of Pediatric Hematology and Oncology, University Hospital Freiburg, Germany., Pietsch T; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany., Andreiuolo F; Institute of Neuropathology, DGNN Brain Tumor Reference Center, University of Bonn Medical Center, Bonn, Germany., Driever PH; Department of Paediatric Haematology/Oncology Charité Universitätsmedizin, Berlin, Germany., Korshunov A; Department of Neuropathology, University Hospital Heidelberg, Germany., Hiddingh L; German Cancer Research Center (DKFZ), Heidelberg, Germany., Worst BC; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Sturm D; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Zuckermann M; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Witt O; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Bloom T; BRAIN UK, University of Southampton, Southampton, United Kingdom., Mitchell C; BRAIN UK, University of Southampton, Southampton, United Kingdom., Miele E; Department of Onco-haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Colafati GS; Oncological Neuroradiology Unit, Department of Diagnostic Imaging, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Diomedi-Camassei F; Department of Laboratories - Pathology Unit, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Bailey S; Newcastle Hospitals NHS Foundation Trust, Newcastle, United Kingdom., Moore AS; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, Australia.; Oncology Service, Queensland Children's Hospital, Brisbane, Australia.; Child Health Research Centre, The University of Queensland, South Brisbane, Australia., Hassall TEG; Oncology Service, Queensland Children's Hospital, Brisbane, Australia.; Institute for Molecular Bioscience, The University of Queensland, St Lucia, Australia.; School of Biomedical Sciences, Faculty of Health, Queensland University of Technology, Brisbane, Australia., Lowis SP; Brain Tumour Research Centre, University of Bristol, Bristol, United Kingdom., Tsoli M; Children's Cancer Institute, University of New South Wales, Sydney, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia., Cowley MJ; Children's Cancer Institute, University of New South Wales, Sydney, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia., Ziegler DS; Children's Cancer Institute, University of New South Wales, Sydney, Australia.; Kids Cancer Centre, Sydney Children's Hospital, Randwick, Australia., Karajannis MA; Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, New York., Aquilina K; Department of Neurosurgery, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom., Hargrave DR; Department of Paediatric Oncology, Great Ormond Street Hospital NHS Foundation Trust, London, United Kingdom., Carceller F; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., Marshall LV; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom.; Children & Young People's Unit, Royal Marsden Hospital NHS Trust, Sutton, United Kingdom., von Deimling A; Department of Neuropathology, University Hospital Heidelberg, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Centre Göttingen, Germany., Pfister SM; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany., Sahm F; Department of Paediatric Haematology/Oncology Charité Universitätsmedizin, Berlin, Germany.; Clinical Cooperation Unit Neuropathology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Baker SJ; Department of Neurobiology, St. Jude Children's Research Hospital, Memphis, Tennessee., Mastronuzzi A; Neuro-oncology Unit, Department of Onco-haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Carai A; Oncological Neurosurgery Unit, Department of Neuroscience and Neurorehabilitation, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Vinci M; Department of Onco-haematology, Cell and Gene Therapy, Bambino Gesù Children's Hospital-IRCCS, Rome, Italy., Capper D; Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Neuropathology, Berlin, Germany.; German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany., Popov S; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom.; Department of Pathology, University of Wales Hospital NHS Trust, Cardiff, United Kingdom., Ellison DW; Department of Neuropathology, St. Jude Children's Research Hospital, Memphis, Tennessee. chris.jones@icr.ac.uk david.jones@kitz-heidelberg.de t.jacques@ucl.ac.uk david.ellison@stjude.org., Jacques TS; UCL Great Ormond Street Institute of Child Health, London, United Kingdom. chris.jones@icr.ac.uk david.jones@kitz-heidelberg.de t.jacques@ucl.ac.uk david.ellison@stjude.org., Jones DTW; German Cancer Research Center (DKFZ), Heidelberg, Germany. chris.jones@icr.ac.uk david.jones@kitz-heidelberg.de t.jacques@ucl.ac.uk david.ellison@stjude.org.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Jones C; Division of Molecular Pathology, Institute of Cancer Research, London, United Kingdom. chris.jones@icr.ac.uk david.jones@kitz-heidelberg.de t.jacques@ucl.ac.uk david.ellison@stjude.org.
Publikováno v:
Cancer discovery [Cancer Discov] 2020 Jul; Vol. 10 (7), pp. 942-963. Date of Electronic Publication: 2020 Apr 01.
Autor:
Loveday C; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Litchfield K; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Proszek PZ; The Centre for Molecular Pathology, The Royal Marsden NHS Trust, Sutton, London, UK., Cornish AJ; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Santo F; The Centre for Molecular Pathology, The Royal Marsden NHS Trust, Sutton, London, UK., Levy M; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Macintyre G; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Holryod A; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Broderick P; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Dudakia D; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Benton B; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK., Bakir MA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Hiley C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK., Grist E; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London, UK.; Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, London, UK., Huddart R; Academic Radiotherapy Unit, Institute of Cancer Research, London, UK., Powles T; Barts Cancer Institute, Queen Mary University, London, UK., Chowdhury S; Department of Oncology, Guys and St Thomas' NHS Foundation Trust, London, UK., Shipley J; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.; Division of Cancer Therapeutics, The Institute of Cancer Research, London, UK., O'Connor S; The Centre for Molecular Pathology, The Royal Marsden NHS Trust, Sutton, London, UK.; Addenbrooke's Hospital, Cambridge, UK.; Department of Oncology, University of Cambridge, Cambridge, UK., Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK., Reid A; Academic Uro-oncology Unit, The Royal Marsden NHS Foundation Trust, Sutton, London, UK., de Castro DG; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK., Houlston RS; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK.; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Turnbull C; Division of Genetics & Epidemiology, The Institute of Cancer Research, London, UK. clare.turnbull@icr.ac.uk.; William Harvey Research Institute, Queen Mary University, London, UK. clare.turnbull@icr.ac.uk.; Guys and St Thomas' NHS Foundation Trust, Great Maze Pond, London, UK. clare.turnbull@icr.ac.uk.; Public Health England, National Cancer Registration and Analysis Service, London, UK. clare.turnbull@icr.ac.uk.
Publikováno v:
Nature communications [Nat Commun] 2020 May 04; Vol. 11 (1), pp. 2189. Date of Electronic Publication: 2020 May 04.
Autor:
Mansukhani S; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Barber LJ; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Kleftogiannis D; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Moorcraft SY; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Davidson M; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Woolston A; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Proszek PZ; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, Sutton, UK., Griffiths B; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Fenwick K; Tumour Profiling Unit, The Institute of Cancer Research, London, UK., Herman B; Diagnostics and Genomics Group, Agilent Technologies Inc., Santa Clara, CA., Matthews N; Tumour Profiling Unit, The Institute of Cancer Research, London, UK., O'Leary B; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK., Hulkki S; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, Sutton, UK., Gonzalez De Castro D; Centre for Cancer Research and Cell Biology, Belfast, UK., Patel A; Department for Radiology, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Wotherspoon A; Department of Histopathology, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Okachi A; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Rana I; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Begum R; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Davies MN; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Powles T; Barts Cancer Institute, Queen Mary University of London, London, UK., von Loga K; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Hubank M; Centre for Molecular Pathology, The Royal Marsden NHS Foundation Trust, Sutton, UK., Turner N; Breast Cancer Now Research Centre, The Institute of Cancer Research, London, UK.; Breast Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Watkins D; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Chau I; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Cunningham D; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Lise S; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Starling N; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK., Gerlinger M; Centre for Evolution and Cancer, Division of Molecular Pathology, The Institute of Cancer Research, London, UK; marco.gerlinger@icr.ac.uk.; Gastrointestinal Cancer Unit, The Royal Marsden NHS Foundation Trust, London and Sutton, UK.
Publikováno v:
Clinical chemistry [Clin Chem] 2018 Nov; Vol. 64 (11), pp. 1626-1635. Date of Electronic Publication: 2018 Aug 27.
Autor:
Shah V; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Sherborne AL; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Walker BA; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Johnson DC; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Boyle EM; Department of Haematology, Hopital Huriez, CHRU, Lille, France., Ellis S; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Begum DB; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Proszek PZ; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Jones JR; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Pawlyn C; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Savola S; MRC Holland, Amsterdam, The Netherlands., Jenner MW; Department of Haematology, University Hospital Southampton, Southampton, UK., Drayson MT; Clinical Immunology, School of Immunity & Infection, University of Birmingham, Birmingham, UK., Owen RG; Department of Haematology, St James's University Hospital, Leeds, UK., Houlston RS; Division of Molecular Pathology, The Institute of Cancer Research, London, UK., Cairns DA; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Gregory WM; Clinical Trials Research Unit, University of Leeds, Leeds, UK., Cook G; Section of Experimental Haematology, Leeds Institute of Cancer & Pathology, University of Leeds, Leeds, UK., Davies FE; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Jackson GH; Department of Haematology, Newcastle University, Newcastle upon Tyne, UK., Morgan GJ; MIRT, University of Arkansas for Medical Sciences, Little Rock, AR, USA., Kaiser MF; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Publikováno v:
Leukemia [Leukemia] 2018 Jan; Vol. 32 (1), pp. 102-110. Date of Electronic Publication: 2017 Jun 06.